United Therapeutics Corp.
Net Cash Flow Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
FY2009
Total Cash from Operations: $960.8M
| Line Item | Value | % of Total |
|---|---|---|
| Capital Expenditures | $138.8M | 14.4% |
| Other Investing | $672.7M | 70.0% |
| Working Capital | $82.9M | 8.6% |
| Net Cash Flow | $66.4M | 6.9% |